BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15357516)

  • 1. NCCN makes changes to its guidelines for treating fever and neutropenia.
    National Comprehensive Cancer Network (NCCN)
    J Support Oncol; 2004; 2(4):319, 355. PubMed ID: 15357516
    [No Abstract]   [Full Text] [Related]  

  • 2. NCCN guidelines advocate wider use of colony-stimulating factor.
    McNeil C
    J Natl Cancer Inst; 2005 May; 97(10):710-1. PubMed ID: 15900037
    [No Abstract]   [Full Text] [Related]  

  • 3. Methodology for clinical trials in cancer patients with febrile neutropenia. Do we have a consensus?
    Feld R
    Support Care Cancer; 1998 Sep; 6(5):423-4. PubMed ID: 9773456
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evidence-based management of neutropenia and fever].
    Ishiguro H; Fung MC; Sakata T; Morizane T; Adachi S
    Gan To Kagaku Ryoho; 2003 Sep; 30(9):1365-71. PubMed ID: 14518423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.
    Flowers CR; Seidenfeld J; Bow EJ; Karten C; Gleason C; Hawley DK; Kuderer NM; Langston AA; Marr KA; Rolston KV; Ramsey SD
    J Clin Oncol; 2013 Feb; 31(6):794-810. PubMed ID: 23319691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A general description of the clinical guideline for the management of febrile neutropenia].
    Takamatsu Y
    Gan To Kagaku Ryoho; 2013 Jun; 40(6):697-702. PubMed ID: 23863646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibiotics in patients with fever and neutropenia].
    Kern WV
    Dtsch Med Wochenschr; 2013 Jun; 138(23):1217-20. PubMed ID: 23720174
    [No Abstract]   [Full Text] [Related]  

  • 8. [Myelosuppression due to antineoplastic agents].
    Shigeoka Y; Shimizu E
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():287-93. PubMed ID: 18074550
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of growth factors with antibiotics in the setting of neutropenic fever.
    Hussein AM; Elkordy M; Peters WP
    Am J Med; 1996 Jan; 100(1):15-6. PubMed ID: 8579081
    [No Abstract]   [Full Text] [Related]  

  • 10. Fever, neutropenia, and the second law of thermodynamics.
    Baden LR; Rubin RH
    Ann Intern Med; 2002 Jul; 137(2):123-4. PubMed ID: 12118968
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of febrile neutropenia].
    Urabe A
    Rinsho Ketsueki; 2009 Feb; 50(2):69-72. PubMed ID: 19265296
    [No Abstract]   [Full Text] [Related]  

  • 12. NCCN: Fever and neutropenia.
    Wade JC; Rubenstein EB;
    Cancer Control; 2001; 8(6 Suppl 2):16-21. PubMed ID: 11760554
    [No Abstract]   [Full Text] [Related]  

  • 13. Treating low-risk febrile neutropenia: Jenny's story.
    Phillips R; Skinner R; Chisholm JC
    Arch Dis Child; 2007 Jan; 92(1):7-8. PubMed ID: 17185442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Empirical antimicrobial treatment for chemotherapy-induced febrile neutropenia.
    Bal AM; Gould IM
    Int J Antimicrob Agents; 2007 May; 29(5):501-9. PubMed ID: 17346939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Problems and proposals for revision of the Japanese guideline for febrile neutropenia].
    Yoshida M
    Rinsho Ketsueki; 2011 Apr; 52(4):182-9. PubMed ID: 21566403
    [No Abstract]   [Full Text] [Related]  

  • 16. Which children with fever and neutropenia can be safely treated as outpatients?
    Mullen CA
    Br J Haematol; 2001 Mar; 112(4):832-7. PubMed ID: 11298578
    [No Abstract]   [Full Text] [Related]  

  • 17. Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update.
    Taplitz RA; Kennedy EB; Bow EJ; Crews J; Gleason C; Hawley DK; Langston AA; Nastoupil LJ; Rajotte M; Rolston K; Strasfeld L; Flowers CR
    J Clin Oncol; 2018 May; 36(14):1443-1453. PubMed ID: 29461916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of febrile neutropenia in an acute oncology service.
    Sammut SJ; Mazhar D
    QJM; 2012 Apr; 105(4):327-36. PubMed ID: 22080099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New strategies in the treatment of infectious complications in haematology and oncology: is there a role for out-patient antibiotic treatment of febrile neutropenia?
    Karthaus M; Carratalà J; Jürgens H; Ganser A
    Chemotherapy; 1998; 44(6):427-35. PubMed ID: 9755304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction to the Australian consensus guidelines for the management of neutropenic fever in adult cancer patients, 2010/2011. Australian Consensus Guidelines 2011 Steering Committee.
    Lingaratnam S; Slavin MA; Koczwara B; Seymour JF; Szer J; Underhill C; Prince M; Mileshkin L; O'Reilly M; Kirsa SW; Bennett CA; Davis ID; Morrissey O; Thursky KA;
    Intern Med J; 2011 Jan; 41(1b):75-81. PubMed ID: 21272171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.